Various secretory phospholipase A2 enzymes are expressed in rheumatoid arthritis and augment prostaglandin production in cultured synovial cells

FEBS Journal

Volumn 272, Issue 3, 2005, Pages 655-672

  Masuda, Seiko ^a   Murakami, Makoto ^a   Komiyama, Kazuo ^b   Ishihara, Motoko ^c   Ishikawa, Yukio ^c   Ishii, Toshiharu ^c   Kudo, Ichiro ^a  

^a SHOWA UNIVERSITY   (Japan)

^b NIHON UNIVERSITY   (Japan)

^c TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Immunohistochemistry; Phospholipase A2; Prostaglandin; Rheumatoid arthritis; Synovial cell

Indexed keywords

ADENOVIRUS VECTOR; ARACHIDONIC ACID; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 1BETA; PHOSPHOLIPASE A2; PROSTAGLANDIN; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA; PHOSPHOLIPASE A;

ARACHIDONIC ACID METABOLISM; ARTICLE; CAPILLARY ENDOTHELIUM; CARTILAGE CELL; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH FOLLICLE; NORTHERN BLOTTING; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; SYNOVIOCYTE; VASCULAR SMOOTH MUSCLE; BIOSYNTHESIS; CELL CULTURE; CONFOCAL MICROSCOPY; METABOLISM; PATHOLOGY; SYNOVIUM; WESTERN BLOTTING;

ADENOVIRIDAE;

ARTHRITIS, RHEUMATOID; BLOTTING, NORTHERN; BLOTTING, WESTERN; CELLS, CULTURED; DINOPROSTONE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; IMMUNOHISTOCHEMISTRY; MICROSCOPY, CONFOCAL; PHOSPHOLIPASES A; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SYNOVIAL MEMBRANE;

EID: 13444263475     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2004.04489.x     Document Type: Article

References (74)

1. 2S. Adv Immunol 77, 163-194.
2. 2 enzymes. Prostaglandins Other Lipid Mediat 68-69, 3-58.
3. 2 production by blocking mRNA synthesis and post-transcriptional expression. J Biol Chem 265, 12745-12748.
4. 2. J Biol Chem 269, 2365-2368.
5. 2s containing 16 cysteines. J Biol Chem 269, 23018-23024.
6. 2. J Biol Chem 272, 15745-15752.
7. 2S. J Biol Chem 274, 24973-24979.
8. 2S. J Biol Chem 275, 5785-5793.
9. 2. Cloning, tissue distribution, and functional expression of two novel mouse group II enzymes. J Biol Chem 274, 31195-31202.
10. 2 with homology to the group III bee venom enzyme. J Biol Chem 275, 7492-7496.
11. 2. J Biol Chem 275, 39823-39826.
12. 2S preferentially expressed in type 2 helper T cells. J Biol Chem 276, 18321-18326.
13. 2 expression and function by proinflammatory stimuli. Eur J Biochem 263, 826-835.
14. 2 is expressed in human colon carcinoma cells and human mast cells and upregulated in mouse inflammatory tissues. Eur J Biochem 269, 2698-2707.
15. 2. Biochem Biophys Res Commun 292, 689-696.
16. 2 by rat mesangial cells. Its contribution to arachidonic acid release and prostaglandin synthesis by cultured rat glomerular cells. J Clin Invest 92, 2516-2523.
17. 2. J Biol Chem 273, 14411-14423.
18. 2S and cyclooxygenases in immediate and delayed prostanoid biosynthetic pathways. J Biol Chem 274, 3103-3115.
19. 2 with the glycosyl phosphatidylinositol-anchored heparan sulfate proteoglycan in the cyclooxygenase-2-mediated delayed prostanoid biosynthetic pathway. J Biol Chem 274, 29927-29936.
20. 2S in regulating arachidonic acid release and prostaglandin generation: implication of cyclooxygenase-2 induction and phospholipid scramblase-mediated cellular membrane perturbation. J Biol Chem 274, 31435-31444.
21. 2S in human embryonic kidney 293 and rat mastocytoma RBL-2H3 cells through heparan sulfate shuttling and external plasma membrane mechanisms. J Biol Chem 271, 30041-30051.
22. 2. J Biol Chem 277, 19145-19155.
23. 2S (group III and XII). J Biol Chem 278, 10657-10667.
24. 2 in rodents during inflammation. Biochim Biophys Acta 1635, 37-47.
25. 2 internalization and degradation. J Biol Chem 276, 11126-11134.
26. 2. J Biol Chem 274, 11881-11888.
27. 2. J Biol Chem 277, 9358-9365.
28. 2-independent cysteinyl leukotriene synthesis in human eosinophils. J Biol Chem 278, 38813-38820.
29. 2. Proc Natl Acad Sci USA 95, 7951-7956.
30. 2S. J Biol Chem 274, 12263-12268.
31. 2 in caveolin-enriched granules in activated P388D1 macrophage-like cells. J Biol Chem 278, 48059-48065.
32. 2 induced prominent release of arachidonic acid from human myeloid leukemia cells. J Biol Chem 274, 34203-34211.
33. 2 but not the group IB, IIA, and V enzymes efficiently release arachidonic acid from adherent mammalian cells. J Biol Chem 275, 3179-3191.
34. 2 in ARDS pathogenesis. Mol Med Today 5, 244-249.
35. 2. J Biol Chem 277, 5849-5857.
36. 2. J Immunol 166, 4029-4034.
37. 2 and decorin in human atherosclerotic lesions. Circ Res 86, 707-714.
38. 2 in vascular disease. Circ Res 89, 298-304.
39. Min-induced intestinal neoplasia. Cell 81, 957-966.
40. 2 synthesis in mast cells. J Immunol 165, 4007-4014.
41. 2: a mediator between proximal and distal effectors of inflammation. Immunol Today 12, 143-146.
42. 2. J Biol Chem 264, 5768-5775.
43. 2a. J Biol Chem 279, 25024-25038.
44. 2. Trends Pharmacol Sci 20, 162-170.
45. 2 production by membrane-bound prostaglandin E synthase-2 via both cyclooxygenases-1 and -2. J Biol Chem 278, 37937-37947.
46. 2 antigen in arthritic synovium. Ann Rheum Dis 57, 550-558.
47. 2 up-regulates cyclooxygenase-2 and amplifies cytokine-mediated prostaglandin production in human rheumatoid synoviocytes. J Immunol 165, 2790-2797.
48. 2. Arthritis Rheum 37, 653-661.
49. 2 blocks inflammation, hyperalgesia, and interleukin 6 production in vivo. J Exp Med 184, 883-891.
50. 2. J Immunol 155, 3570-3577.
51. Vane JP & Botting RM (1995) New insights into the mode of action of anti-inflammatory drugs. Inflamm Res 44, 1-10.
52. 2α-deficient mice are resistant to collagen-induced arthritis. J Exp Med 197, 1297-1302.
53. Myers LK, Kang AH, Postlethwaite AE, Rosloniec EF, Morham SG, Shlopov BV, Goorha S & Ballou LR (2000) The genetic ablation of cyclooxygenase 2 prevents the development of autoimmune arthritis. Arthritis Rheum 43, 2687-2693.
54. Trebino CE, Stock JL, Gibbons CP, Naiman BM, Wachtmann TS, Umland JP, Pandher K, Lapointe JM, Saha S, Roach ML et al. (2003) Impaired inflammatory and pain responses in mice lacking an inducible prostaglandin E synthase. Proc Natl Acad Sci USA 100, 9044-9049.
55. 2 receptors in the pathogenesis of rheumatoid arthritis. J Clin Invest 110, 651-658.
56. Siegle I, Klein T, Backman JT, Saal JG, Nusing RM & Fritz P (1998) Expression of cyclooxygenase 1 and cyclooxygenase 2 in human synovial tissue: differential elevation of cyclooxygenase 2 in inflammatory joint diseases. Arthritis Rheum 41, 122-129.
57. 2 in cultured rat astrocytes. J Biol Chem 275, 10876-10886.
58. 2: quantitative analysis of expression and secretion and determination of the localization and routing in rat mesangial cells. Biochim Biophys Acta 1530, 86-96.
59. 2 in murine epidermis. J Invest Dermatol 121, 156-164.
60. Nabi IR & Le PU (2003) Caveolae/raft-dependent endocytosis. J Cell Biol 161, 673-677.
61. van Deurs B, Roepstorff K, Hommelgaard AM & Sandvig K (2003) Caveolae: anchored, multifunctional platforms in the lipid ocean. Trends Cell Biol 13, 92-100.
62. 2 catalytic domain modulates association and residence time at Golgi membranes. J Biol Chem 279, 6005-6016.
63. 2. FEBS Lett 268, 113-116.
64. 2 induce cytokine release from blood and synovial fluid monocytes. Eur J Immunol 32, 67-76.
65. 2 in zymosan-induced eicosanoid generation and vascular permeability revealed by targeted gene disruption. J Biol Chem 279, 16488-16494.
66. 2a activity that is responsible for arachidonic acid release. J Biol Chem 278, 24153-24163.
67. 2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells. Cell 80, 919-927.
68. 2 family, is associated with lymphotoxin deficiency. Genes Immun 1, 191-199.
69. Tumanov AV, Grivennikov SI, Shakhov AN, Rybtsov SA, Koroleva EP, Takeda J, Nedospasov SA & Kuprash DV (2003) Dissecting the role of lymphotoxin in lymphoid organs by conditional targeting. Immunol Rev 195, 106-116.
70. 2S in human neutrophils: role in eicosanoid production and gram-negative bacterial phospholipid hydrolysis. J Biol Chem 277, 5061-5073.
71. 2 expression under hepatocyte injuries by liver diseases. J Gastroenterol Hepatol 19, 1140-1149.
72. 2 biosynthesis. J Biol Chem 275, 32775-32782.
73. Kamei D, Murakami M, Nakatani Y, Ishikawa Y, Ishii T & Kudo I (2003) Potential role of microsomal prostaglandin E synthase-1 in tumorigenesis. J Biol Chem 278, 19396-19405.
74. Clegg DO & Ward JR (1987) Diagnostic criteria in rheumatoid arthritis. Scand J Rheumatol Suppl 65, 3-11.